Research results demonstrate the potential of GM cowpea to enhance yields and profitability for resource-poor farmers.

AI is not a perfect science. Although it's being refined over time, this technology is bound to make mistakes—so there needs ...

Mastering Assistants & Prompts to discover how to use AI to make your work faster, smarter and more creative. This session will engage attendees in situations and questions about their business and ...

A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

In his concluding remarks, Dr. Jitendra Singh reflected on the future of India’s economy, which he asserted would be ...

Equillium, Inc. , a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today ...

Halozyme Therapeutics, Inc. (Halozyme), a biotechnology company that pioneered the use of human hyaluronidase for subcutaneous drug delivery, today filed a patent infringement lawsuit against Merck ...

Lokavant has launched the AI-powered clinical trial forecasting solution, Spectrum v15, to dispel uncertainty in the ...

NurExone's ExoTherapy platform enables precise, minimally-invasive delivery of therapies to injured tissues using exosomes as an advanced delivery system. With a growing body of preclinical data and ...

(Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant traits to seed companies, announced today that two of its disease resistance trait products ...